Targeting lncRNA DDIT4-AS1 Sensitizes Triple Negative Breast Cancer to Chemotherapy via Suppressing of Autophagy

Scientists found that the lncRNA, DNA damage inducible transcript 4 antisense RNA1 (DDIT4-AS1), was highly expressed in triple-negative breast cancer cell lines and tissues due to H3K27 acetylation in the promoter region.